Description In vitro In vivo
ChemicalBook > CAS DataBase List > TAK-733

TAK-733

Description In vitro In vivo
Product Name
TAK-733
CAS No.
1035555-63-5
Chemical Name
TAK-733
Synonyms
CS-547;TAK-733;TAK-733 ，S2617;TAK-733/TAK733;TAK-733 USP/EP/BP;TAK-733, 10 mM in DMSO;(R)-3-(2,3-Dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrim;3-[(2r)-2,3-dihydroxypropyl]-6-fluoro-5-(2-fluoro-4-iodoanilino)-8-methylpyrido[2,3-d]pyrimidine-4,7-dione;(R)-3-(2,3-Dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione;Pyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione, 3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-[(2-fluoro-4-iodophenyl)amino]-8-methyl-
CBNumber
CB42561497
Molecular Formula
C17H15F2IN4O4
Formula Weight
504.23
MOL File
1035555-63-5.mol
More
Less

TAK-733 Property

Boiling point:
530.5±60.0 °C(Predicted)
Density 
1.91±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
≥25.2 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O
form 
solid
pka
13.72±0.20(Predicted)
color 
White to light yellow
More
Less

Safety

HS Code 
2933399990
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
16998
Product name
TAK-733
Purity
≥98%
Packaging
500μg
Price
$33
Updated
2024/03/01
Cayman Chemical
Product number
16998
Product name
TAK-733
Purity
≥98%
Packaging
1mg
Price
$60
Updated
2024/03/01
Cayman Chemical
Product number
16998
Product name
TAK-733
Purity
≥98%
Packaging
5mg
Price
$208
Updated
2024/03/01
Cayman Chemical
Product number
16998
Product name
TAK-733
Purity
≥98%
Packaging
10mg
Price
$380
Updated
2024/03/01
ApexBio Technology
Product number
B1621
Product name
TAK-733
Packaging
50mg
Price
$680
Updated
2021/12/16
More
Less

TAK-733 Chemical Properties,Usage,Production

Description

TAK-733 is a potent and selective MEK allosteric site inhibitor for MEK1 with IC50 of 3.2 nM, inactive to Abl1, AKT3, c-RAF, CamK1, CDK2, c-Met, etc. Phase 1.

In vitro

TAK-733 is highly potent and selective MEK allosteric site inhibitor with IC50 of 3.2 nM. TAK-733 shows potent enzymatic and cell activity with an EC50 of 1.9 nM against ERK phosphorylation in cells.

In vivo

TAK-733 demonstrates broad antitumor activity in mouse xenograft models of human cancer including models of melanoma, colorectal, NSCLC, pancreatic and breast cancer. TAK-733 is well tolerated with pharmacokinetics and pharmacodynamics that support once-daily oral dosing in humans. TAK-733 shows maximally efficacious doses at once daily orally doses of 10 mg/kg.

Uses

TAK-733 is a potent and selective MEK allosteric site inhibitor with an IC50 of 3.2 nM.

Biological Activity

tak-733 is a potent, atp-noncompetitive and selective inhibitor of mek allosteric site with the ic50 value of 3.2nm [1].tak-733 has been shown potent enzymatic and cell activity with an ic50 value of 3.2nm against constitutively active mek enzyme and an ec50 of 1.9nm against erk phosphorylation in cells. in addition, tak-733 has also shown the low clearance and high oral bioavailability based on the pharmacokinetics of tak-733 in all species (mouse, rat, dog and monkey). furthermore, tak-733 has been reported to broad inhibit tumor activity in mouse xenograft models of human cancer (melanoma, colorectal, nsclc, pancreatic and breast cancer) [1].

Synthesis

1035555-51-1

1035555-63-5

Example 18: (i) To a solution of 3-(2,3-dihydroxypropyl)-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidin-4,7(3H,8H)-dione (Example 6) (1 g, 2.06 mmol, 1 eq.) in DMF (19 mL) was added dropwise under nitrogen protection at ambient temperature a solution of Selectfluor (801 mg, 2.26 mmol, 1.1 eq.) in a mixture of acetonitrile (9 mL) and DMF (5 mL). The reaction mixture was stirred at ambient temperature for 10 minutes and then filtered. The filtrate was purified by preparative LC/MS (30-55% CH3CN/H2O) to afford (R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione (Example 18) as an off-white solid. The recovered feedstock was reacted under the same reaction conditions to give a second batch of product. The total yield was 347 mg (33%).1H NMR (400 MHz, DMSO-J6) δ ppm 3.36-3.40 (m, 1H), 3.43-3.50 (m, 1H), 3.58 (s, 3H), 3.61-3.72 (m, 1H), 3.72-3.82 (m, 1H), 4.27-4.37 (m, 1H) , 4.78-4.87 (m, 1H), 5.14 (d, J = 5.81 Hz, 1H), 6.93-7.03 (m, 1H), 7.53 (d, J = 8.84 Hz, 1H), 7.65-7.74 (m, 1H), 8.52 (s, 1H), 10.25 (d, J = 10.1 Hz, 1H). The calculated value for [M + H] C17H15F2IN4O4 is 505; the measured value is 505.

in vivo

The pharmacokinetics of TAK-733 is evaluated in nude mouse, rat, dog and monkey. Low clearance and high oral bioavailability are observed in all species. TAK-733 demonstrates broad antitumor activity in mouse xenograft models of human cancer including models of melanoma, colorectal, NSCLC, pancreatic and breast cancer[1]. Daily oral administration of 1, 3, 10, and 30 mg/kg of TAK-733 for 14 days (Days 10 to 23) results in tumor growth delay in the A375 cell-implanted mice (5/group). TAK-733 (35, 70, 100, and 160 mg/kg) also significantly inhibits tumor growth on an intermittent dosing schedule of 3 days per week for 2 weeks (Days 10, 13, 15, 17, 20, and 22). Three partial regressions (PR), a 60% response rate, are observed in mice administered with 30 mg/kg of TAK-733 daily and in mice administered with 160 mg/kg of TAK-733 intermittently. Responses, CR (complete regression) and partial regressions (PR) are also observed in mice administered with 70, 100, and 160 mg/kg of TAK-733 intermittently. The tumor regression rate is more pronounced with the intermittent administration regimen; the greatest reduction in tumor volume is observed at 160 mg/kg (57.29%), versus a maximum reduction of 46.97% at 30 mg/kg once daily. By the last day of administration, tumor growth is significantly (p<0.05 for %T/C, Student's t-test) inhibited in mice administered 3, 10, and 30 mg/kg once daily or 35, 70, 100, and 160 mg/kg intermittently[2].

target

MEK1

IC 50

MEK: 3.2 nM (IC50)

References

[1] dong q1, dougan dr, gong x, halkowycz p, jin b, kanouni t, o'connell sm, scorah n, shi l, wallace mb, zhou f. discovery of tak-733, a potent and selective mek allosteric site inhibitor for the treatment of cancer. bioorg med chem lett. 2011 mar 1;21(5):1315-9. doi: 10.1016/j.bmcl.2011.01.071. epub 2011 jan 22.

TAK-733 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

TAK-733 Suppliers

China 106 India 1 United States 15 Global 122
MedChemexpress LLC
Tel
021-58955995
Fax
609-228-5909
Email
sales@medchemexpress.cn
Country
United States
ProdList
4861
Advantage
58
AdooQ BioScience, LLC
Tel
+1 (866) 930-6790
Fax
+1 (866) 333-9607
Email
info@adooq.com
Country
United States
ProdList
2782
Advantage
58
Target molecule Corp.
Tel
857-239-0968
Fax
857-239-8801
Email
service1@targetmol.com
Country
United States
ProdList
2559
Advantage
60
Musechem
Tel
+1-800-259-7612
Fax
+1-800-259-7612
Email
info@musechem.com
Country
United States
ProdList
4660
Advantage
60
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58
Cckinase, Inc.
Tel
+1 (732)236-3202
Email
sales@cckinase.com
Country
United States
ProdList
2738
Advantage
58
Aladdin Scientific
Tel
Email
tp@aladdinsci.com
Country
United States
ProdList
57505
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354;
Email
support@targetmol.com
Country
United States
ProdList
39035
Advantage
58
ApexBio Technology
Tel
--
Fax
--
Email
sales@apexbt.com
Country
United States
ProdList
6251
Advantage
58
BOC Sciences
Tel
16314854226
Email
info@bocsci.com
Country
United States
ProdList
9923
Advantage
65
Santa Cruz Biotechnology, Inc.
Tel
--
Fax
--
Email
scbt@scbt.com
Country
United States
ProdList
3597
Advantage
60
Selleck Chemicals LLC
Tel
--
Fax
--
Email
info@selleckchem.com
Country
United States
ProdList
824
Advantage
60
Cayman Chemical Company
Tel
--
Fax
--
Email
cayman@caymanchem.com
Country
United States
ProdList
6213
Advantage
81
Creative Enzymes
Tel
--
Fax
--
Email
info@creative-enzymes.com
Country
United States
ProdList
6057
Advantage
58
Matrix Scientific
Tel
--
Fax
--
Email
sales@matrixscientific.com
Country
United States
ProdList
6632
Advantage
80
More
Less

View Lastest Price from TAK-733 manufacturers

Career Henan Chemical Co
Product
TAK-733 1035555-63-5
Price
US $3.00/KG
Min. Order
1KG
Purity
99%
Supply Ability
100kg
Release date
2019-08-06

1035555-63-5, TAK-733Related Search:

6-[(7S)-7-Hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthalenecarboxamide ARRY-424704, ARRY-704 Selumetinib Tipifarnib Trametinib PLX4032 Fedratinib RESATORVID TAK-063 Vonoprazan fumarate INK1117 Mobocertinib Tak 799 TAK-960 Soticlestat TAK-632 TAK875 Benzoic acid, 4-[[(cyclopropylmethyl)[4-(2-fluorophenoxy)benzoyl]amino]methyl]-

  • TAK-733
  • TAK-733/TAK733
  • (R)-3-(2,3-Dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione
  • (R)-3-(2,3-Dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione TAK 733
  • (R)-3-(2,3-Dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrim
  • CS-547
  • 3-[(2r)-2,3-dihydroxypropyl]-6-fluoro-5-(2-fluoro-4-iodoanilino)-8-methylpyrido[2,3-d]pyrimidine-4,7-dione
  • Pyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione, 3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-[(2-fluoro-4-iodophenyl)amino]-8-methyl-
  • TAK-733 USP/EP/BP
  • TAK-733, 10 mM in DMSO
  • TAK-733 ，S2617
  • 1035555-63-5
  • C17H15F2IN4O4
  • Inhibitors
  • MAPK